Press Releases about Acorda TherapeuticsFrom Acorda Therapeutics
Via Business Wire
Acorda Therapeutics Reports Third Quarter 2022 Financial Results
November 01, 2022
From Acorda Therapeutics
Via Business Wire
From Acorda Therapeutics
Via Business Wire
Acorda Shareholders Invited to Virtual Q&A with CEO Ron Cohen, M.D.
October 21, 2022
From Acorda Therapeutics
Via Business Wire
Via Business Wire
Via Business Wire
John Varian Joins Acorda Therapeutics Board of Directors
January 03, 2022
Via Business Wire
Via Business Wire
Acorda Third Quarter 2021 Update: Webcast Scheduled for November 9, 2021
November 02, 2021
Via Business Wire
Acorda Therapeutics Announces Corporate Restructuring, Management Changes
September 09, 2021
Via Business Wire
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|